| Document Date: 2013-09-22 14:46:24
Open Document File Size: 328,42 KBShare Result on Facebook
Company GW Pharmaceuticals / Bayer AG / Hortapharm AG / Blockbuster / / Continent Europe / / Country Germany / United Kingdom / / / Event M&A / Business Partnership / / IndustryTerm pharmaceutical industry / acetyl / treatment for severe neuropathic pain and multiplesclerosis symptoms / oil / contract manufacturing partners / / MedicalCondition disease / menstrual cramps / fever / pain / multiple sclerosis / allergic reactions / irritation / inflammation / / Organization Royal Society of London / MHRA / FDA / Medicines and Healthcare Products Regulatory Agency / / Person Geoffrey Guy / Edward Stone / Felix Hofmann / David Watson / Robert Clarke / Dave Watson / / Position editor / pharmaceutical entrepreneur / chemist / / Product Tylenol / / ProvinceOrState California / / PublishedMedium Scientific American / /
SocialTag |
O’Shaughnessy’s • Summer 2003 —17— Bayer Buys Rights to Market GWP’s Cannabis Extract By Fred Gardner GW Pharmaceuticals, the British company that has conducted successful clinical trials of cannabis-based